Craft

Sophia Genetics

Stock Price

$4.7

2024-07-12

Market Capitalization

$304.6 M

2024-07-12

Revenue

$40.5 M

FY, 2021

Sophia Genetics Summary

Company Summary

Overview
Sophia Genetics is a healthcare technology company focused on establishing the practice of data-driven medicine. It builds a cloud-based SaaS platform that analyzes data and generates insights from multimodal data sets and different diagnostic modalities. It also standardizes, computes, and analyzes digital health data and enables healthcare institutions to share knowledge and experiences and to build a collective intelligence.
Type
Public
Status
Active
Founded
2011
HQ
Saint-Sulpice, CH | view all locations
Website
https://www.sophiagenetics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jurgi Camblong

    Jurgi Camblong, Founder and CEO, Director

  • Lara Hashimoto

    Lara Hashimoto, SVP – Chief Business Officer

  • Philippe Menu

    Philippe Menu, SVP – Chief Medical Officer

  • Ross Muken

    Ross Muken, SVP – Chief Financial Officer

Operating MetricsView all

Platform Analysis Volume

243.4K
51.1%

FY, 2021

New Recurring Platform Customers

90
83.7%

FY, 2021

Annual Net Dollar Retention Rate

142.0%
29.1%

FY, 2021

LocationsView all

4 locations detected

  • Saint-Sulpice, Vaud HQ

    Switzerland

    Rue du Centre 172

  • Boston, MA

    United States

    185 Dartmouth St #502

  • Bidart, Nouvelle-Aquitaine

    France

    374 All. Antoine d'Abbadie bâtiment A

  • Rolle, VD

    Switzerland

    La Pièce 12

Sophia Genetics Financials

Summary Financials

Revenue (Q3, 2022)
$11.6M
Gross profit (Q3, 2022)
$7.3M
Net income (Q3, 2022)
($23.3M)
Cash (Q3, 2022)
$157.8M
EBIT (Q3, 2022)
($23.6M)
Enterprise value
$163.1M

Footer menu